Oyster Point Pharma P/E Ratio

Oyster Point Pharma (OYST) currently reports a P/E ratio of -2.79. That is below the Healthcare sector average of 26.36. Use the charts on this page to explore Oyster Point Pharma's P/E ratio history and peer comparisons.

Oyster Point Pharma's P/E ratio of -2.79 is lower than the Healthcare sector average of 26.36. That is roughly 110.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Oyster Point Pharma's market price to a fundamental measure such as earnings, sales, or book value. At -2.79, OYST can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -2.79, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 26.36. From there, open related valuation or income-statement pages for Oyster Point Pharma, and consider following OYST for alerts when major investors trade the stock.

Oyster Point Pharma is classified in the Healthcare sector. On P/E ratio, it currently shows -2.79 versus a sector average near 26.36. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OYST with unrelated industries.